Bifunctional degraders of hematopoietic progenitor kinase and therapeutic uses thereof
US12091426B2 · kind B2 · utility
0Cited by
1References
29Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 9, 2022 |
| Grant date | Sep 17, 2024 |
| Priority date | — |
| Expiry date | Dec 1, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides bifunctional compounds as HPK1 degraders via ubiquitin proteasome pathway, and method for treating diseases modulated by HPK1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.